HealthEquity Statistics
Total Valuation
HealthEquity has a market cap or net worth of $9.07 billion. The enterprise value is $9.89 billion.
| Market Cap | 9.07B |
| Enterprise Value | 9.89B |
Important Dates
The last earnings date was Tuesday, June 3, 2025, after market close.
| Earnings Date | Jun 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HealthEquity has 86.48 million shares outstanding. The number of shares has increased by 1.53% in one year.
| Current Share Class | 86.48M |
| Shares Outstanding | 86.48M |
| Shares Change (YoY) | +1.53% |
| Shares Change (QoQ) | -0.22% |
| Owned by Insiders (%) | 1.73% |
| Owned by Institutions (%) | 109.69% |
| Float | 84.95M |
Valuation Ratios
The trailing PE ratio is 76.63 and the forward PE ratio is 27.09. HealthEquity's PEG ratio is 1.30.
| PE Ratio | 76.63 |
| Forward PE | 27.09 |
| PS Ratio | 7.33 |
| Forward PS | 6.75 |
| PB Ratio | 4.28 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 26.86 |
| P/OCF Ratio | 26.74 |
| PEG Ratio | 1.30 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.37, with an EV/FCF ratio of 29.28.
| EV / Earnings | 81.18 |
| EV / Sales | 7.96 |
| EV / EBITDA | 24.37 |
| EV / EBIT | 40.62 |
| EV / FCF | 29.28 |
Financial Position
The company has a current ratio of 4.06, with a Debt / Equity ratio of 0.52.
| Current Ratio | 4.06 |
| Quick Ratio | 3.47 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 2.70 |
| Debt / FCF | 3.28 |
| Interest Coverage | 3.82 |
Financial Efficiency
Return on equity (ROE) is 5.77% and return on invested capital (ROIC) is 4.82%.
| Return on Equity (ROE) | 5.77% |
| Return on Assets (ROA) | 4.57% |
| Return on Invested Capital (ROIC) | 4.82% |
| Return on Capital Employed (ROCE) | 7.38% |
| Revenue Per Employee | $398,404 |
| Profits Per Employee | $39,040 |
| Employee Count | 3,120 |
| Asset Turnover | 0.37 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HealthEquity has paid $31.94 million in taxes.
| Income Tax | 31.94M |
| Effective Tax Rate | 20.78% |
Stock Price Statistics
The stock price has increased by +26.65% in the last 52 weeks. The beta is 0.49, so HealthEquity's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +26.65% |
| 50-Day Moving Average | 97.32 |
| 200-Day Moving Average | 95.32 |
| Relative Strength Index (RSI) | 56.70 |
| Average Volume (20 Days) | 1,284,941 |
Short Selling Information
The latest short interest is 5.26 million, so 6.09% of the outstanding shares have been sold short.
| Short Interest | 5.26M |
| Short Previous Month | 5.96M |
| Short % of Shares Out | 6.09% |
| Short % of Float | 6.20% |
| Short Ratio (days to cover) | 4.41 |
Income Statement
In the last 12 months, HealthEquity had revenue of $1.24 billion and earned $121.81 million in profits. Earnings per share was $1.37.
| Revenue | 1.24B |
| Gross Profit | 814.43M |
| Operating Income | 243.45M |
| Pretax Income | 98.27M |
| Net Income | 121.81M |
| EBITDA | 405.70M |
| EBIT | 243.45M |
| Earnings Per Share (EPS) | $1.37 |
Balance Sheet
The company has $287.89 million in cash and $1.11 billion in debt, giving a net cash position of -$818.86 million or -$9.47 per share.
| Cash & Cash Equivalents | 287.89M |
| Total Debt | 1.11B |
| Net Cash | -818.86M |
| Net Cash Per Share | -$9.47 |
| Equity (Book Value) | 2.12B |
| Book Value Per Share | 24.49 |
| Working Capital | 356.45M |
Cash Flow
In the last 12 months, operating cash flow was $339.17 million and capital expenditures -$1.45 million, giving a free cash flow of $337.72 million.
| Operating Cash Flow | 339.17M |
| Capital Expenditures | -1.45M |
| Free Cash Flow | 337.72M |
| FCF Per Share | $3.91 |
Margins
Gross margin is 65.52%, with operating and profit margins of 19.59% and 9.80%.
| Gross Margin | 65.52% |
| Operating Margin | 19.59% |
| Pretax Margin | 12.37% |
| Profit Margin | 9.80% |
| EBITDA Margin | 32.64% |
| EBIT Margin | 19.59% |
| FCF Margin | 27.17% |
Dividends & Yields
HealthEquity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.53% |
| Shareholder Yield | -1.53% |
| Earnings Yield | 1.34% |
| FCF Yield | 3.72% |
Analyst Forecast
The average price target for HealthEquity is $117.00, which is 11.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $117.00 |
| Price Target Difference | 11.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HealthEquity has an Altman Z-Score of 4.39 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.39 |
| Piotroski F-Score | 6 |